Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats

The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) expos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2004-06, Vol.493 (1), p.111-115
Hauptverfasser: Masood, Anbrin, Banerji, Basudeb, Vijayan, V.K., Ray, Arunabha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 115
container_issue 1
container_start_page 111
container_title European journal of pharmacology
container_volume 493
creator Masood, Anbrin
Banerji, Basudeb
Vijayan, V.K.
Ray, Arunabha
description The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor, l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors, N-nitro- l-arginine methyl ester ( l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO x) as compared to that of single restraint stress exposure. Further, in l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.
doi_str_mv 10.1016/j.ejphar.2004.04.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72014141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299904004030</els_id><sourcerecordid>72014141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</originalsourceid><addsrcrecordid>eNp9kF1rHCEUhiW0JJuPf1CKN83dbHR0PrwplJCmhUBykVyLH2e6Z5kZp-qW9N_H7S60V8WDojzvwfMQ8oGzNWe8vdmuYbtsTFzXjMn1vnh_Qla871TFOl6_IyvGuKxqpdQZOU9pyxhrVN2ckjPe8F51HV8RfCotJuPCGH6gMyM1s6cWg9vA9Oee8s4jJBpmmjdAl5AS2hFoDGULA50xR3Q0vKIHinPhI6REjTdLNhlLrDxGk9MleT-YMcHV8bwgL1_vnm-_VQ-P999vvzxUTgqVK2GtbXol2CCGGpz30La2ln3dS95ZaEUjmQPvlZRCCDMA-M44zxU0HR-4FRfk-tB3ieHnDlLWEyYH42hmCLuku7pYKauA8gC6WIaKMOgl4mTib82Z3ivWW31QrPeK9b54X2Ifj_13dgL_N3R0WoBPR8CkYnCIZnaY_uF6JphoC_f5wEGx8Qsh6uQQ5jIcRnBZ-4D__8kbn6udsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72014141</pqid></control><display><type>article</type><title>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Masood, Anbrin ; Banerji, Basudeb ; Vijayan, V.K. ; Ray, Arunabha</creator><creatorcontrib>Masood, Anbrin ; Banerji, Basudeb ; Vijayan, V.K. ; Ray, Arunabha</creatorcontrib><description>The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor, l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors, N-nitro- l-arginine methyl ester ( l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO x) as compared to that of single restraint stress exposure. Further, in l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2004.04.018</identifier><identifier>PMID: 15189771</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adaptation ; Adaptation, Physiological - drug effects ; Adaptation, Physiological - physiology ; Animals ; Arginine - pharmacology ; Arginine - therapeutic use ; Biological and medical sciences ; Brain Chemistry - drug effects ; Drug Evaluation, Preclinical - methods ; Elevated plus maze ; Indazoles - pharmacology ; India ; Male ; Maze Learning - physiology ; Medical sciences ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide - chemistry ; Nitric Oxide - physiology ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; Nitric Oxide Synthase - pharmacology ; NO (Nitric oxide) ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Restraint, Physical - adverse effects ; Restraint, Physical - methods ; Stress ; Stress, Physiological - drug therapy ; Stress, Physiological - metabolism ; Stress, Physiological - physiopathology</subject><ispartof>European journal of pharmacology, 2004-06, Vol.493 (1), p.111-115</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright 2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</citedby><cites>FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014299904004030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15803036$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15189771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masood, Anbrin</creatorcontrib><creatorcontrib>Banerji, Basudeb</creatorcontrib><creatorcontrib>Vijayan, V.K.</creatorcontrib><creatorcontrib>Ray, Arunabha</creatorcontrib><title>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor, l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors, N-nitro- l-arginine methyl ester ( l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO x) as compared to that of single restraint stress exposure. Further, in l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.</description><subject>Adaptation</subject><subject>Adaptation, Physiological - drug effects</subject><subject>Adaptation, Physiological - physiology</subject><subject>Animals</subject><subject>Arginine - pharmacology</subject><subject>Arginine - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Brain Chemistry - drug effects</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Elevated plus maze</subject><subject>Indazoles - pharmacology</subject><subject>India</subject><subject>Male</subject><subject>Maze Learning - physiology</subject><subject>Medical sciences</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide - chemistry</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase - pharmacology</subject><subject>NO (Nitric oxide)</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Restraint, Physical - adverse effects</subject><subject>Restraint, Physical - methods</subject><subject>Stress</subject><subject>Stress, Physiological - drug therapy</subject><subject>Stress, Physiological - metabolism</subject><subject>Stress, Physiological - physiopathology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1rHCEUhiW0JJuPf1CKN83dbHR0PrwplJCmhUBykVyLH2e6Z5kZp-qW9N_H7S60V8WDojzvwfMQ8oGzNWe8vdmuYbtsTFzXjMn1vnh_Qla871TFOl6_IyvGuKxqpdQZOU9pyxhrVN2ckjPe8F51HV8RfCotJuPCGH6gMyM1s6cWg9vA9Oee8s4jJBpmmjdAl5AS2hFoDGULA50xR3Q0vKIHinPhI6REjTdLNhlLrDxGk9MleT-YMcHV8bwgL1_vnm-_VQ-P999vvzxUTgqVK2GtbXol2CCGGpz30La2ln3dS95ZaEUjmQPvlZRCCDMA-M44zxU0HR-4FRfk-tB3ieHnDlLWEyYH42hmCLuku7pYKauA8gC6WIaKMOgl4mTib82Z3ivWW31QrPeK9b54X2Ifj_13dgL_N3R0WoBPR8CkYnCIZnaY_uF6JphoC_f5wEGx8Qsh6uQQ5jIcRnBZ-4D__8kbn6udsw</recordid><startdate>20040616</startdate><enddate>20040616</enddate><creator>Masood, Anbrin</creator><creator>Banerji, Basudeb</creator><creator>Vijayan, V.K.</creator><creator>Ray, Arunabha</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040616</creationdate><title>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</title><author>Masood, Anbrin ; Banerji, Basudeb ; Vijayan, V.K. ; Ray, Arunabha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-3bbb58930f3f2ecdde66b24828417be63540cedd944333afeed7acd19e571f1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adaptation</topic><topic>Adaptation, Physiological - drug effects</topic><topic>Adaptation, Physiological - physiology</topic><topic>Animals</topic><topic>Arginine - pharmacology</topic><topic>Arginine - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Brain Chemistry - drug effects</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Elevated plus maze</topic><topic>Indazoles - pharmacology</topic><topic>India</topic><topic>Male</topic><topic>Maze Learning - physiology</topic><topic>Medical sciences</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide - chemistry</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase - pharmacology</topic><topic>NO (Nitric oxide)</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Restraint, Physical - adverse effects</topic><topic>Restraint, Physical - methods</topic><topic>Stress</topic><topic>Stress, Physiological - drug therapy</topic><topic>Stress, Physiological - metabolism</topic><topic>Stress, Physiological - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masood, Anbrin</creatorcontrib><creatorcontrib>Banerji, Basudeb</creatorcontrib><creatorcontrib>Vijayan, V.K.</creatorcontrib><creatorcontrib>Ray, Arunabha</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masood, Anbrin</au><au>Banerji, Basudeb</au><au>Vijayan, V.K.</au><au>Ray, Arunabha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2004-06-16</date><risdate>2004</risdate><volume>493</volume><issue>1</issue><spage>111</spage><epage>115</epage><pages>111-115</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The involvement of nitric oxide (NO) in stress adaptation was evaluated in rats using the elevated plus maze test. Repeated restraint stress RS(×5) for 5 days resulted in an increase in the percentage number of entries and percentage time spent when compared to a single restraint stress RS(×1) exposure. In the repeated RS treatment groups, the nitric oxide donor, l-arginine (500 and 1000 mg/kg, i.p.) slightly increased the elevated plus maze test parameters when compared to the corresponding vehicle-treated group. The nitric oxide synthase (NOS) inhibitors, N-nitro- l-arginine methyl ester ( l-NAME, 10 and 50 mg/kg, i.p.) and 7-nitroindazole (10 and 50 mg/kg, i.p.) produced differential responses in both the parameters with l-NAME exhibiting greater reduction in open arm entries and open arm time, whereas 7-nitroindazole produced only small differences in both the elevated plus maze parameters. Biochemical data showed that repeated restraint stress resulted in higher levels of brain nitrates and nitrites (NO x) as compared to that of single restraint stress exposure. Further, in l-arginine (1000 mg/kg, i.p.)-treated rats, brain NO x was lowest in the single restraint stress group, followed by repeated restraint stress and (no restraint stress) controls. The results are suggestive of the role of nitric oxide in stress adaptation and this may be due to the effects of restraint stress on brain NOS activity.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15189771</pmid><doi>10.1016/j.ejphar.2004.04.018</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2004-06, Vol.493 (1), p.111-115
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_72014141
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adaptation
Adaptation, Physiological - drug effects
Adaptation, Physiological - physiology
Animals
Arginine - pharmacology
Arginine - therapeutic use
Biological and medical sciences
Brain Chemistry - drug effects
Drug Evaluation, Preclinical - methods
Elevated plus maze
Indazoles - pharmacology
India
Male
Maze Learning - physiology
Medical sciences
NG-Nitroarginine Methyl Ester - pharmacology
Nitric Oxide - chemistry
Nitric Oxide - physiology
Nitric Oxide Synthase - antagonists & inhibitors
Nitric Oxide Synthase - pharmacology
NO (Nitric oxide)
Pharmacology. Drug treatments
Rats
Rats, Wistar
Restraint, Physical - adverse effects
Restraint, Physical - methods
Stress
Stress, Physiological - drug therapy
Stress, Physiological - metabolism
Stress, Physiological - physiopathology
title Pharmacological and biochemical studies on the possible role of nitric oxide in stress adaptation in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A19%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20and%20biochemical%20studies%20on%20the%20possible%20role%20of%20nitric%20oxide%20in%20stress%20adaptation%20in%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Masood,%20Anbrin&rft.date=2004-06-16&rft.volume=493&rft.issue=1&rft.spage=111&rft.epage=115&rft.pages=111-115&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2004.04.018&rft_dat=%3Cproquest_cross%3E72014141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72014141&rft_id=info:pmid/15189771&rft_els_id=S0014299904004030&rfr_iscdi=true